Since the development of both GCA and PMR as consequences of PD-1/PD-L1 inhibition therapy of cancer patients has been reported (79, 80), the use of these radiotracers for the imaging of GCA and PMR may potentially worsen the disease and is therefore not feasible. This evidence concerns the gene CD274 and temporal arteritis.